Position
Squarepoint Ops LLC in Dyne Therapeutics, Inc.
Back to the book · All holders of DYN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$364.9K$19.56 → $18.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 255.2K | $4.99M | — | — | — | 0.0% |
| Q1 2026 | 834.2K | $15.1M | $18.13 | −$364.9K | $10.5M | 0.0% |